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ABSTRACT
Shama Moktan: Antibiotics Resistance Pattern in Northern Mississippi Wetlands
(Under the direction of Dr. Lydia Halda-Alija)
Bacterial resistance to antibacterial agents is a condition in which there is no
susceptibility or decreased susceptibility to antibacterial agents that ordinarily cause cell
death or inhibition of bacteria. Bacterial resistance to antibacterial agents is a quantitative
measurement of the efficiency or concentration expressed in micrograms per milliliter or
as inhibition zones in millimeters for the diffusion technique of an antibacterial agent
against a specific bacterium. In vitro methods for measurement of antibacterial activity
are available that are based on testing increased concentrations  of antibacterial agent
against a bacterial isolate to identify at which concentration the growth of the bacterium
is inhibited. The lowest concentration at which detectable growth is inhibited is known as
the minimum inhibitory concentration (MIC) of the antibacterial agent. Indeed the MIC
indicates the relative measurement of the smallest concentration of antibacterial agent
required to inhibit the growth (cell division) of  a bacterium.
Bacterial isolates from clinical environment are regularly tested for antibiotics
susceptibility. Clinical isolates are selected for antibiotic susceptibility testing to monitor
antibiotic resistance and multidrug-resistance so as to enhance medical therapy. However,
with the increasing use of antibiotics outside the clinical area, it has become necessary to
determine the antibiotics susceptibility of environmental bacterial isolates. It has become
important to determine the spread of resistant organisms throughout the environment.
Ill
Environmental isolates obtained from northern Mississippi wetlands were tested for
antibiotic susceptibility to different class of antibiotics including novel antibiotics.
Antibiotics susceptibility testing of the environmental isolates classified as being
pathogenic were done using microdilution protocol specified by the National Committee
on Clinical Laboratory Standards (NCCLS). The degree of growth response of each
isolate in response to a particular antibiotic was recorded. Antibiotic potency for a
particular isolate was determined in terms of the IC50 concentration (antibiotic
concentration that affords only 50% growth of the bacteria), the minimum inhibitory
concentration (lowest concentration of the antibiotic at which growth of bacteria is
limited) and the minimum bactericidal concentration (the minimum concentration of the
antibiotic at which growth of the organism is completely inhibited). MIC values of the
antibiotics in the presence of each environmental isolate were compared to the MIC
interpretative standards ((/xg/ml) for Enterobacteriacae according to NCCLS. Data from
different antibiotics susceptibility testing suggested that the environmental isolates were
resistant to the earlier generation of p-lactam class of antibiotics. On the contrary.
resistance to tetracycline, a commonly used antibiotic in agriculture, was found to be
intermediate. The environmental isolates were generally susceptible to newer generation
of P-lactams, such as cefoxitin and ceftazidime. Antibiotic resistance to p-lactams is
mainly attributed to the production of p-lactamase enzyme by bacteria that hydrolyzes the
p-lactam ring of the P-lactams and reduces the effect of p-lactams. The newer
generations of p-lactams possess a bulkier structure around the p-lactam ring to resist the
IV
action of p-lactamase enzyme. The results of this study suggest that environmental P-
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The emergence of antibiotic resistance in bacterial populations is a concerning
issue for clinicians, health workers and the general public. Antibiotic resistance confers
bacteria the ability to resist the effect of the antibiotic. Antibiotic resistant bacterial
infection becomes more difficult to treat because the bacteria causing the infection cannot
be killed or reduced by traditional antibiotics. Traditional antibacterial therapy becomes
more difficult because the selection of antibiotics for the treatment is narrowed.
Bacterial resistance to an antibacterial agent is best described and defined in
relation to bacterial susceptibility to that antibacterial agent. Bacterial resistance to
antibacterial agents is a condition in which there is no susceptibility or decreased
susceptibility to antibacterial agents that ordinarily cause cell death or inhibition of
bacteria. Bacterial resistance to antibacterial agents is a quantitative measurement of the
efficiency or concentration expressed in micrograms per milliliter or as inhibition zones
in millimeters for the diffusion technique of an antibacterial agent against a specific
bacterium (Madigan et al. 2002). It is a property of bacteria to resist the effect of
antibiotics.
Extrinsic factors such as the concentration of a given antibiotic, duration of
exposure to the antibiotics and availability of a given carbon source may regulate the
expression of antibiotic resistance towards the antibiotic (e.g. Martinez and Baquero
2000). In vitro and in vivo studies have indicated that increased fitness may not always be
the result of antibiotic resistant mutation (Levy 1992). However, should an antibiotic
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resistant mutant be selective over the wild-type counterpart, it suggests that the antibiotic
resistant mutation has conferred increased fitness to the bacteria.
Bacterial resistance to antibiotics can be either natural (intrinsic) or acquired.
Antibiotic resistance can be encoded by the bacterial chromosome or by extra-
chromosomal entities called plasmids (Levy 1992). The resistance gene encoded in the
chromosome is most likely a result of mutation within the chromosome which makes it
an intrinsic property. Furthermore, the bacterial chromosome is stable and does not
participate in horizontal gene transfer like the plasmid does. Therefore, antibiotic
resistance genes encoded by the chromosome are usually not directly transmissible, at
least horizontally. Antibiotic resistance can also be encoded in the plasmid level on so-
called resistance plasmids (R factors) (Madigan et al. 2002). The resistance gene encoded
in the plasmid, is most likely a result of acquisition of that gene from another bacteria.
Therefore, antibiotic resistance through plasmid-encoded genes is an acquired property of
the bacteria.
Plasmid-mediated transfer of antibiotic genes is possible through horizontal gene
transfer. In the bacterial populations, horizontal gene transfer is carried out through the
processes of transformation, conjugation and transduction. Transformation is simply the
uptake of a “naked” DNA fragment by a bacterial cell, its further incorporation into the
cell’s genome or into plasmid and eventually, its expression in a chromosomal level or in
a plasmid-level. Conjugation involves the transfer of plasmid DNA copy from a donor
bacterial cell to a recipient cell. This mechanism requires direct cell to cell contact which
is established through a special structure called pilus. Pili are seen only during the
process of conjugation. The genetic material is transferred through this cell-cell bridge.
3
Transduction involves plasmid transfer via bacteriophages. When bacteriophages infect a
bacterial cell, they exploit the bacterial genome for viral protein synthesis. The bacterial
genome gets integrated with viral genome. After lysis and upon subsequent infections of
other bacterial cells by these viruses, the previous bacterial genome gets transferred into
other bacterial cells.
There are several mechanisms of antibiotic resistance in the bacterial population.
As mentioned earlier, the genetic basis of these mechanisms could be either chromosomal
or plasmid mediated or in some cases both.
Antibiotic resistance could be an intrinsic phenomenon for some bacteria due to
the difference in cell features. For instance, a large portion of the bacterial population is
either gram-negative or gram-positive. The difference between gram-negative and gram¬
positive bacteria is the cell wall (Figure 1). The gram-negative cell wall is a multilayered
structure and quite complex, whereas the gram-positive cell wall consists primarily a
single type of molecule and is often thicker (Madigan et al. 2002). Due to their protective
outer membrane gram-negative bacteria are exclusively resistant to antibiotics that target
cell wall synthesis inhibition, as opposed to gram-positive bacteria which are not. Some
common antibiotics that target cell wall synthesis inhibition are ampicillin and penicillin.
Although both penicillin and ampicillin belong to the jS-lactam class of antibiotics, unlike
penicillin, ampicillin is a broad spectrum antibiotic.
4
Figure 1. Gram-positive and gram-negative cell wall
Source: Available from URL: http://vv\\ \v.arclics.uaa.cdu ~-emilvcL theorv.html
Figure 1.1: A Gram-positive cell wall
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Figure 1.2: A Gram-negative cell wall
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In addition some gram negative bacteria such as Pseudomonas aeruginosa and enteric
bacteria have reduced permeability to penicillins (Madigan et al. 2002). Antibiotic
resistance can also be achieved by altering the target site of the antibiotics. Studies have
shown an alteration in DNA gyrase, a chief site of target of quinolones (Madigan et al.
2002). Alteration of a biochemical pathway that an antibiotic blocks can also confer
antibiotic resistance to that antibiotic.
Antibiotic resistance that is plasmid encoded has been observed in the inactivation
of antibiotic by the production of certain enzymes by bacteria. Staphylococcus aureus
produce enzymes whose genes are encoded by the plasmid, that are capable of resistance
towards aminoglycosides (Madigan et al. 2002). Plasmid mediated tetracycline resistance
is also seen in enteric bacteria that are capable of tetracycline efflux through proteins that
are plasmid encoded (Madigan et al. 2002). Bacteria capable of tetracycline efflux
actively prevent the entry of tetracycline into the cell leading to decreased penetration of
the drug into the cell (Levy 1984).
The result of antibiotic resistance through both chromosomal origin or plasmid
mediation, in addition to selective factors including the type of antibiotic, allows bacteria
to inhibit the mode of action of that particular antibiotic. In other words, the mutant
bacteria are now able to impede the antibiotic’s functions at the target site. For example.
antibiotics belonging to the /?-lactam class (penicillin, cephalosporin) (Figure 2) disrupt
the formation of peptidoglycan layer in the cell wall of most bacteria. The result of which
kills the bacteria by osmotic effect. However, bacteria possessing the j8-lactamase gene
produce the jS-lactamase enzyme that is able to hydrolyze the /?-lactam ring of /3-lactam
antibiotics. The bacteria which would initially have been susceptible to the /3-lactam
6
antibiotics are now resistant to its action. They are able to grow in the presence of these
antibiotics.
Another antibiotic resistance related phenomenon has been multidrug resistance
among various species of bacteria. Multidrug resistance among Enterobacteriaceae in the
hospital setting is an increasing problem (Leverstein-van Hall, et al. 2002). In two
separate studies conducted by Guerra, et al. and Leverstein-van Hall, et al. in 2001,
spread and contribution of multidrug resistance was seen associated with plasmid
mediation.
Emergence of antibiotic resistance patterns in bacteria in clinical settings have
been extensively studied and documented. The appearance of antibiotic resistant
pathogenic strains in nosocomial infection has become a trend. Vancomycin resistant
Enterococcus sp. in nosocomial infections is one of them. In most cases, resistance to a
new antibiotic arises within 3 years of the antibiotic’s FDA approval date (Medieros
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Mechanism of action of different classes of antibiotics
There are a vast number of antibiotics that are commercially available. An
antibiotic can be either bacteriostatic or bactericidal. A bacteriostatic antibiotic limits the
growth of bacteria. A bactericidal antibiotic clears the bacterial population. The strength
of an antibiotic is determined by its concentration at which 50% growth of the bacteria is
inhibited (IC50), its minimum inhibitory concentration (MIC) and its minimum
bactericidal concentration (MBC). The minimum inhibitory concentration is the lowest
concentration of the antibiotic which supports no visibly detectable growth of the
bacteria. The minimum bactericidal concentration is the lowest concentration that kills
100% of the bacteria.
Antibiotics are classified under different classes on the basis of their mechanism
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jS-Lactams are types of antibiotics that target the penicillin-binding-proteins (PBP)
in the bacterial cell wall. PBP are enzymes that provide peptidoglycan linkages within the
cell wall. By targeting this crucial protein needed for the synthesis of bacterial cell wall,
0-lactams actively stimulate autolysins in bacteria (Levy 1992). Some widely used 0-
Lactams are ampicillin, penicillin and cephalosporins.
Presumably, the use and overuse of 0-lactams over the years has applied selective
pressures on the bacterial population to counteract the effect of 0-lactams. The emergence of
the 0-lactamase gene in gram negative bacilli was seen in the early 1960s. 0-lactamases
hydrolyze the amide-bond in the 0-lactam ring. This reduces the fimction of 0-lactams. The
most notable 0-lactamases are the TEM-1 and SHV-1 (sulfahydryl variant) and their variants.
TEM-1 and SHV-1 preferentially hydrolyze the 0-lactam ring of penicillin. However,
variants of these 0-lactamases can arise from single point mutation in the genes that encode
these enzymes. The variants arising from such mutations are capable of acting on an
extended-spectrum of 0-lactam antibiotics and are called extended-spectrum 0-lactamase
(ESBL) (Bradford 2001).
The gene encoding the TEM-1 0-lactamase is plasmid and transposon mediated
which accounts for the wide-spread occurrence of this particular enzyme in the bacterial
population. It is found in many different species of members of the family
Enterobacteriaceae. Pseudomonas aeruginosa, Haemophilus influenzae, and Neisseria
gonorrhoea. Up to 90% of ampicillin resistance in E.coli is due to the production of TEM-1
(Bradford 2001). TEM-3 was the first 0-lactamase identified to express an extended-
spectrum-0-lactam (ESBL) phenotype. There are over 25 different variants of SHV that have
been described. SHV-1 0-lactamase is usually plasmid mediated in Escherichia coli
(Bradford 2001).
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Clinically significant and nonrepeat isolates of E. coli and Klebsiella sp sampled for a
period of 1 year in 12 participating Canadian tertiary care hospitals have been found to
produce ESBL belonging to Amber’s molecular class  A(Mulvey, et al. 2004). Although
Mulvey et al., indicate that the number of ESBL producers in Canada are relatively lower
than other countries (approximately 5 to 15% oiKlebsiella sp. and 2 to 10% ofE. coli strains
harboring ESBL(s) have been surveyed in U. S hospitals), their results point to the an
alarming concern that ESBL producers have already gained a foothold in the bacterial pool
associated with nosocomial infections.
This is where the use of jS-lactamase inhibitor in tandem with /3-lactam comes into
play for the treatment jS-lactam resistant infections. jS-lactam/jS-lactamase inhibitor
combinations in treatment of various infections produced at least as efficacious, if not
superior results compared to conventional regimen of antibiotics (Lee, et al. 2003).
In vitro combination of the third generation cephalosporin. Ceftazidime and the jS-
lactamase inhibitor Sulbactam decreased the growth of ESBL producing Klebsiella
pneumoniae and E. coli (Lavigne, et al. 2004).
12
Antibiotic Resistance in Non-Clinical Setting
Another arena where appearance of antibiotic resistant bacteria has also been
observed is in the environment. The extensive use of antibiotics in the animal feed.
agriculture, etc. can provide easy route for antibiotics to leak into the environment and
contribute to the selection of antibiotic resistant bacterial populations there. This situation
is further enhanced by the non-medical use of antibiotics as a prophylactic and growth
enhancement measures in livestock and domestic animals feeds as well. The discovery
that antibiotics can improve the growth rate of animals, in the early 1950s, on the basis of
yet unkno>vn mechanisms, led to the massive use of these drugs as food additives
(Amabile-Cuevas 1993) in animal feed.
Increased introduction of antimicrobial agents into the environment via medical
therapy, agriculture, and animal husbandry has resulted in new selective pressures on
bacterial populations (Col and O’Conner 1987). In the United States alone, 40,000 -
50,000 pounds of antibiotics are used each year just for the control of bacterial infections
of fruit trees (Levy 1992). Wide spread usage of antimicrobial agents cause strain on
bacteria that are constantly exposed to these agents leading to selection of resistant
bacteria. Resistance to antibiotics becomes a necessity for the growth and survival of
bacteria.
The use of antibiotics is not restricted to treatment of clinical diseases due to
bacterial infection(s) in humans and animals. Antibiotics are constantly used for
controlling vegetable and fruit infections as well. For example, streptomycin and
oxytetracycline are used for fire blight and bacterial spots in plants, respectively (Levy
1992). In addition, antibiotics such as oxytetracycline, sulfamerazine are used to treat
13
ulcers or furunculoses of the skin of the fish (Levy 1992). Additionally, tetracycline is
also widely used in the catfish and the salmon industry for treatment of infections.
Especially since salmon farming requires placing the salmon pen in natural sea waters,
antibiotics resistant strains of bacteria created by these farms will have contact with other
marine life (Levy 1992). Consequently this situation poses a selective force for producing
more resistant bacterial strains in yet another environmental niche (Levy 1992).
Incidentally, tetracycline is added in animal feed for treatment of disease, prophylactic
use and as a growth promoter. In a different study conducted by Chee-Stanford, et al.
(2001) isolates from groundwater samples and lagoons used for swine waste disposal
were analyzed. The researchers identified the tetracycline resistance gene in isolates jfrom
groundwater and lagoons associated with swine farms.
The isolation of resident stream species fi-om a river downstream of a wastewater
treatment plant discharge fi’om the Arga River in Spain recovered enterobacteria and
Aeromonas strains. These isolates showed increased resistance to several antibiotics
including nalidixic acid, tetracycline, jS-lactam, and co-trimoxazole. The percentage of
acquired resistance for enterobacteria was less than for the Aeromonas strains (Goni-
Urriza, et al. 2000). Researchers project that this could be due to the resistance bacteria
that are passing through the treatment process and conferring resistance to native bacteria
(McArthur and Tuckfield 2000).
Recent evidence also suggests that heavy metal concentration (Mercury) in the
sediments may be the strongest predictor of antibiotic resistance (McArthur and
Tuckfield 2000). Bacterial resistance to streptomycin and kanamycin were positively
correlated with sediment mercury concentration in streams below nuclear reactors and
14
industrial facilities, a result of indirect selection of metal tolerance (McArthur and
Tuckfield 2000).
A class of antibiotics known as quinolones is widely used in veterinary medicine,
particularly in Europe. These antibiotics, however, are excreted as unchanged substances
and are among the most persistent drugs in the environment (Goni-Urriza, et al. 2002).
Quinolone resistance in environmental isolates from two European rivers (the Arga River
in Spain and the Garonne River in France) has been identified. Quinolone resistance is
due to the alteration of the target enzymes, the type II bacterial topoisomerases (Goni-
Urriza, et al. 2002).
Resistant bacteria selected in animals and plants may not directly cause diseases
in humans. However, it is likely that they contribute their resistance genes into the
environmental pool. Thereafter, horizontal gene transfer can enable the transfer of the
resistance genes to bacteria that do cause diseases in humans.
15
Why study bacterial isolates from non-clinical environment?
It is important to study bacterial isolates from non-clinical environment and not
just clinical environment for antibiotic resistance in order to monitor the spread of
antibiotic resistance or even multidrug resistance in the environment. Effective
compilation of the antibiotic patterns can be used as a useful environmental indicator of
contamination in the environment due to direct or indirect anthropogenic effects.
Bacterial isolates for this study were collected from wetland environment (Halda-
Alija 2003). Antibiotic resistance pattern of these environmental isolates can be
established using National Center for Clinical Laboratory Standards (NCCLS) designed
protocols on antibiotic susceptibility testing.
Previous data have shown that monitoring the response of antibiotic resistant
enteric bacteria, rather than the entire assemblage, is a potentially productive approach to
the examination of the responses of natural populations of bacteria to anthropogenic
disturbances (e.g. Halda-Alija and Subgani 2004; Halda-Alija, et al. 2000). In previous
studies, bacteria samples were obtained from sediment samples from pristine
environment, wetland sediments and the rhizosphere of Juncus effusus L (Halda-Alija
and Subgani 2004). The Enterobacter spp., Aeromonas spp.. Pseudomonas spp., and
Bacillus spp., were isolated. Bacterial samples from the rhizosphere were also included
because genetic exchange and transfer of antibiotic resistance genes may be enhanced in
the rhizosphere (Halda-Alija 2003). Bacterial isolates were subjected to antibiotics
susceptibility testing with different antibiotics with different mechanisms of action (Table
1). Antibiotic susceptibility was determined by the plate agar and disk diffusion tests. The
rate of acquired ampicillin resistance (<50|ng/ml) was high for ampicillin for 98 out of
16
137 (72%) of the bacteria tested (Halda-Alija and Subgani 2004). The rate of resistance
to ampicillin suggests acquired resistance to ampicillin (Halda-Alija and Subgani 2004).
The rate of acquired resistance was low (>10 to 20 pg/ml) for kanamycin, tetracycline
and chloramphenicol for all strains tested. These preliminary findings suggested that the
isolates are particularly resistant to jS-Lactams.
Escherichia coli is considered the most widely studied species of bacteria, and
the family Enterobacteriacae as a whole is the best studied group of microorganisms
(Halda-Alija 2001). Enterobacteriacae are ubiquitous. They are distributed worldwide
and are found in water and soil (Halda-Alija et al. 2000; Halda-Alija et al. 2001) and as
normal intestinal flora in humans and many animals (Grimont and Grimont 1992). They
are responsible for a wide array of human diseases but were rarely reported as pathogens
before widespread use of antibiotics (Schaechter et al. 1999). Conjugation and associated
transfer of antibiotic resistance genes is most readily demonstrated in E. coli and related
members of Enterobacteriacae (Dale 1998). Therefore, we want to assess the antibiotics
susceptibility of the enteric bacteria isolates obtained from the aforementioned non-
clinical environment.
The enteric bacteria isolates were subjected to antibiotics belonging to different
class and having different spectrum of activity (Table 1) for antibiotic susceptibility
testing. The preliminary data suggest that the bacterial isolates were particularly resistant
to antibiotics belonging to the /?-lactam class (Halda-Alija and Subgani 2004). Out of the
bacterial strains that were tested during these preliminary studies, 12 strains were selected
for further susceptibility testing against antibiotics belonging to common chemical
classes (penicillins, cephalosporins, fluoroquinoloes, tetracyclines and macrolides) using
17
NCCLS protocol on antibiotic susceptibility testing. A novel class of antibiotic,
oxazolidinones was also included in this susceptibility testing. In addition
chloramphenicol was included in this antibiotic susceptibility testing. Chloramphenicol is
primarily bacteriostatic and inhibits bacterial protein synthesis by binding to the 50s
subunit of bacterial ribosome. It has a wide spectrum activity against gram-positive and
gram-negative bacteria.
A modified version of the broth microdilution protocol designed by the National
Center for Clinical Laboratory Standards (NCCLS M100-S12 2002; NCCLS M7-A5
2000) was employed for antibiotic susceptibility testing of the environmental isolates.
NCCLS laboratory guidelines and procedures are standardized consensus through
participation by individual laboratories, laboratory professional associations, industries
and government agencies. Therefore, NCCLS standards represent selective criteria for
effective outcome (NCCLS M7-A5 2000).
Antibiotic susceptibility testing of the environmental isolates was also performed
with different generations of jS-lactams and /3-lactamase inhibitors. This was done to





In vitro methods for measurement of antibacterial activity are available that are
based on testing increased concentrations of antibacterial agent against a bacterial isolate
to identify at which concentration the growth of the bacterium is inhibited. Conventional
methods of antibiotics susceptibility assessment include disk diffusion technique in which
the zone of inhibition is measured in millimeters. The diameter of the zone of inhibition
can be used to identify whether a bacterial strain is resistant or susceptible to an
antibiotic. The results of conventional methods such as the disk diffusion technique for
antibiotic susceptibility are generally verified by other methods as well. Alternative
methods are adapted in order to confirm the selective bacterial populations that are
resistant to antibiotics. The microdilution procedure for antibiotics susceptibility testing
used in this study is selected for its high throughput screening capacity. It is based on
NCCLS protocol for dilution antimicrobial susceptibility tests for bacteria that grow
aerobically (NCCLS M7-A5 2000).
Bacteria strains:
Bacterial isolates were identified and categorized. Following bacterial strains have been
used in this study:
48 J2 124FDl 132 67
F7F18 FD2 D3F5 FI
Quality Control Strains:
Escherichia coli ATCC® 25922, Escherichia coli ATCC® 35218 and
Enterobacteria cloacae ATCC® 13047 strains from American Type Culture Collection,
19
Rockville, MD were used as reference strains as per quality control guidelines set by
NCCLS (NCCLS M7-A5 2000).
Short-term storage of the bacteria and the quality control strains:
Bacterial strains were streaked on Eugon agar (Difco, Detroit, MI) Petri plates.
The agar plates were incubated at 37“C for 24 hours. The plates were stored at 4‘’C for
future use.
Antibiotics storage:
All antibiotics in this study were dissolved in Dimethyl Sulfoxide (DMSO),
except for gentamycin, neomycin, kanamycin and streptomycin that were dissolved in
nanopure water. The antibiotics were dissolved to  a concentration of 5.12 mg/ml.
Aliquots (SOjul) of antibiotic solutions were stored in the first column of a 96 well flat
bottomed microplates (Costar) at -70°C.
Antibiotics Dilution:
On the day of the assay, the microplate containing the antibiotic solutions is
removed from the freezer and allowed to thaw. The antibiotics in column #1 are diluted
five times in sterile 0.9% saline. Then they are serially diluted three-fold until colimrn #
11. Column #12, except the last two wells, contains only DMSO. DMSO is also diluted
five times in 0.9% saline and represents the negative control of the assay. Thus, the
concentration of the antibiotic samples in the dilution plate is between 1.024 mg/ml and
5.202 X 10'^ mg/ml. The diluted antibiotics are transferred in duplicates to a new
microplate.
Preparation of bacterial inocula:
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On the day of the assay, 1-2 colonies of the strain were transferred from the
Eugon agar plates to sterile 0.9 % 3 ml saline. 0.5 McFarland suspension (5/il of 48mM
BaCb + 995^1 of 180mM H2SO4) was prepared (NCCLS M7-A5 2000). The bacterial
suspensions in saline and the 0.5 McFarland suspension were agitated on a vortex mixer
to ensure uniform turbidity. Thereafter, 100 /tl from each bacterial suspension, 0.5
McFarland suspension, 0.9% saline and 180mM H2SO4 were transferred in duplicates to
a new 96 well microplate. The absorptions of the saline suspension were compared to that
of 0.5 McFarland suspension at 630nm using the El-340 Biokinetics Reader (Bio-Tek
Instruments, Vermont). The result of which was used to evaluate the inoculum size of
enteric bacteria in Mueller-Hinton broth (at pH 7.3) to achieve a final target inoculum of
5.0 X 10^ Colony Forming Unit/ml (NCCLS M7-A5 2000) after addition to the
antibiotics. Normally, turbidity of 0.5 McFarland standard is comparable to turbidity of a
Q
cell suspension with 1.5 x 10 CFU/ml. Therefore, turbidity of bacterial suspension was
calculated using the following expression:
Turbidity of bacterial suspension = average (bacteria - saline) x 1.5 x 10^ CFU/ml
average (O.5-H2SO4)
The inoculum size that needs to be added to the media to achieve a final target inoculum
of 5.0 X 10^ CFU/ml is calculated after multiplying the turbidity of each bacterial
suspension with the following number:
20 ml * Number of plates *5x10^ CFU/ml x 1000 /tl/ml * (200/175)
Antibacterial Assay:
21
Finally, the inoculum calculated was added to the required volume of cation-
adjusted Mueller-Hinton broth (at pH 7.3). Then 175.0 /xl of the inoculum was pipetted to
the diluted antibiotic samples to achieve a final volume of 200 /il. The final test
concentration range of the antibiotic samples was now between 128 /ig/ml and
0.002/xg/ml. A 0 hour reading at 630nm of all the plates was taken.
The microtiter plates were incubated at 37*0 for 24 hours. After the incubation
period was over, each plate was sealed with SealPlate (Sigma-Aldrich, St. Louis, MO)
and gently shaken to ensure that all the cells are in suspension. Then a 24 hour reading
was taken for all plates at 630nm.
The antimicrobial assay is based on the difference of optical density readings of a
particular strain at 0 hour and at 24 hour in the presence of antibiotic samples. The
difference in the optical readings corresponds to the growth or lack of growth of that
strain in response to the antibiotic samples. The antimicrobial assay used in this study
allows to quantify the growth of a particular bacterial strain in response to serial
concentrations of a specific antibiotic. It uses bacterial inoculum with Dimethyl Sulfoxide
(DMSO) as the negative control (because DMSO should not inhibit growth). The last two
wells of the last column of the 96 flat-bottom microtiter plate are designated for media
(200 pi) only. The media represents the blank and no growth is anticipated in these two
wells.
Any effect due to blank is subtracted out fi-om the temporal difference of optical
densities of a bacterial strain in response to the serial concentrations of a particular
antibiotic. This gives the net growth of the bacterial strain in response to a particular
antibiotic. The net growth is then compared to the average of the optical densities of the
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negative controls. The ratio between the net growth of the bacterial strain in the presence
of antibiotic and in the absence of antibiotic (negative controls) is multiplied with 100%
to give % growth of the bacterial strain.
IC50, MIC and MBC Determination:
These % growth values of each bacterial strain were plotted against serial
dilutions of the antibiotic. The x-axis was presented in the log scale to encompass a wider
range of concentration values in a small space. In a log scale the spacing between two
data points allows for adequate placement to represent the serial dilution range of the
antibiotics used in the assay. It also enables a better viewing of points of interception.
The % growth values or the growth curve was made to intercept the x-axis at 50%.
Therefore, the point of interception of the growth curve on the x-axis was recorded as the
IC50 value of that antibiotic (Figures 3-9).
The MIC was determined by observing the microtiter plate and selecting the well
at which there was no visible sign of growth of the bacteria. The corresponding
concentration of that well was determined to be the MIC of that antibiotic.
To determine the MBC, 5 jitl from each well that showed no apparent signs of
growth were transferred to Nutrient agar (Difco) Petri plates. The agar plates were
incubated at 37°C for 20 - 24 hours. The lowest concentration that did not allow growth
or recovery of the organism on the agar plate was selected to be MBC.
Standard deviation and average of IC50, MIC and MBC values from replicate
studies of each antibiotic was determined using Microsoft Excel 2002. MIC and MBC
values of the second antibiotics susceptibility testing and the /3-lactam antibiotics
susceptibility testing were graphed using GraphPad Prism (Figure 10 and 11).
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Figure 3. Growth curves of bacterial strain J2
Figure 3.1: Growth curves of J2 showing IC50S for Erythromycin, Ampicillin and
Tetracycline at 15.0, 3.5, and 0.15 gg/ml, respectively from the general antibiotics
susceptibility testing
Figure 3.2: Growth curves^ of J2 showing IC50S for Erythromycin, Ampicillin and
Tetracycline at 20.0, 9.5 and 0.15 pg/ml, respectively. Growth curve® against
Cephalosporin C shows no inhibition by Cephalosporin C.
“ average of tliree replicates
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Figure 4. Growth curves of bacterial strain FI
Figure 4.1: Growth curves of FI showing IC50S for Erythromycin, Ampicillin and
Tetracycline at 15.0, 15.0, and 0.35 gg/ml, respectively from the general antibiotics
susceptibility testing
Figure 4.2: Growth curves*^ of FI showing IC50S for Erythromycin, Ampicillin and
Tetracycline at 20.0, 9.5 and 0.15 pg/ml, respectively. Growth curve^ against
Cephalosporin C shows no inhibition by Cephalosporin C.
average of three replicates
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Figure 4.3; Growth cur\'cs FI showing IC50S for Ampicillin, Carbenicillin, Cefoxitin,
Ceftazidime and Aztreonam at 6.0, 1.5 0.059, 0.065 and 0.02 gg/ml, respectively. Growth
curve against Bcnzylpenicillin shows no inhibition by Benzylpenicillin.
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Figure 5. Growth curves of bacterial strain F18
Figure 4.1; Growth curv’es of F18 showing ICjos for Erythromycin, Ampicillin and
Tetracycline at 15.0, 20.0, and 0.40 pg/ml, respectively from the general antibiotics
susceptibility testing
Figure 5.2: Growth curves^ of F18 showing IC50S for Erythromycin, Ampicillin and
Tetracycline at 20.0, 9.5, and 0.15 pg/ml, respectively. Growth curve“ against
Cephalosporin C shows no inhibition by Cephalosporin C.
® average of three replicates
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Figure 5.3; Growth curves of FI 8 showing IC50S for Benzylpenicillin, Ampicillin,
Carbenicillin, Cefoxitin, Ceftazidime and Aztreonam and Tazobactam at 80.0,8.0,1.5,
0.03 and 0.04, 0.015 and 75.00 pg/ml, respectively.
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Figure 6. Grow th curves of bacterial strain 48
Figure 6.1; Growth curves of 48 showing IC50S for Erythromycin, Ampicillin and
Tetracycline at 8.0, 4.5, and 0.30 gg/ml, respectively from the general antibiotics
susceptibility testing
Figime 6.2: Growth curves^ of 48 showing IC50S for Erythromycin, Ampicillin and
Tetracycline at 20.0, 9.5, and 0.15 pg/ml, respectively. Growth curve® against
Cephalosporin C shows no inhibition by Cephalosporin C.
average of tliree replicates
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Figure 6.3: Growth cur\ es of 48 showing IC50S for Benzylpenicillin, Ampicillin,
Carbcnicillin, Cefoxitin, Ceftazidime and Aztreonam at 128.0,60.0, 8,0.025,0.075,0.15
and 0.03 pg/ml, respectively.
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Figure 7. Grow th curves of bacterial strain 67
Figure 7.1: Growth curv'es of 67 showing IC50S for Erythromycin, Ampicillin and
Tetracycline at 15.0, 20.0, and 0.40 gg/ml, respectively from the general antibiotics
susceptibility testing
Figure 7.2: Growth curves® of 67 showing IC50S for Erythromycin, Ampicillin and
Tetracycline at 20.0, 9.5, and 0.15 pg/ml, respectively. Growth curve® against
Cephalosporin C shows no inhibition by Cephalosporin C.
“ average of tliree replicates
31
Figure 7.3; Growth curves of 67 show'ing IC50S for Benzylpenicillin, Ampicillin,
Carbcnicillin, Cefoxitin, Ceftazidime and Aztreonam at 70.0, 55.0,80.0,0.015,0.08,0.15
and 0.095 |Jg/ml, respectively.
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Figure 8. Growth curves of bacterial strain FDl
Figure 8.1: Growth curves of FDl showing IC50S for Erythromycin, Ampicillin and
Tetracycline at 1.0, 100.0, and 0.08 gg/ml, respectively from the general antibiotics
susceptibility testing
Figure 8.2: Growth curves^* of FDl showing IC50S for Erythromycin and Tetracycline at
4.5 and 0.50 pg/ml, respectively. Growth curves® against Cephalosporin C and
Ampicillin show no inhibition by Cephalosporin C and Ampicillin, respectively.
average of three replicates
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Figure 9. Growth curves of bacterial strain 124
Figure 9.1: Growth cuiA-es of 124 showing IC50S for Erythromycin, Ampicillin and
Tetracycline at 7.0, 75.0, and 0.08 pg/'ml, respectively from the general antibiotics
susceptibility testing
Figure 9.2: Growth curves^ of 124 showing IC50S for Erythromycin, Ampicillin and
Tetracycline at 20.0, 9.5, and 0.15 pg/ml, respectively. Growth curves^ against
Cephalosporin C shows no inhibition by Cephalosporin C.
average of three replicates
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Figure 9.3: Growth cur\ es of 124 showing IC50S for Benzylpenicillin, Ampicillin,
Carbenicillin, Cefoxitin, Ceftazidime, Aztreonam and Tazobactam at 70.0, 45.0, 80,




The data obtained from 0 and 24 hour readings were analyzed using Z prime -
factor statistical analysis. Z-prime factor is a unitless parameter to evaluate overall assay
quality and validate high throughput screening assays (Zhang, et al. 1999). It basically
looks at the deviation around the controls used in the assay and their averages. If the
deviations of each control do not overlap with the other, then one can “reliably” trust the
data. In other words, if the Z prime-factors of an assay are good for the blank and the
negative controls, then when lack of activity or potent activity of a test sample (in our
case, the antibiotics) is seen, then the assay is more tmstworthy.
The analysis incorporates the average and the standard deviation values for the
positive and the negative controls of the assay. The resulting Z prime-factor indicates
how reliable the assay is. Screening of the assay quality is categorized by the value of the
Z-prime factor of an assay (Zhang, et al., 1999). If the Z prime number is equal to 1, then
the assay is an ideal assay. If 1>Z prime > 0.5, then the assay is excellent. For Z prime <
0.5, deviations of the controls touch or overlap (Zhang, et al., 1999). This could be due to
contamination in the media, incorrect inocula size or manual faults. A Z’-factor is
calculated using the following expression (Zhang, et al., 1999):
Z’ = 1 - ((3 X standard deviation of blank') + (3  x standard deviation of negative control))
average of blank - average of negative control
Three separate antibiotic susceptibility tests of the 12 environmental isolates were
carried out. The preliminary antibiotic susceptibility testing of 12 environmental isolates
was done against antibiotics representing common chemical classes (Table 1). Based on
the results obtained from this experiment, antibiotic susceptibility of the isolates to
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repeated. Cephalosporin C was included
m this experiment as well. For the third antibiotic susceptibility testing, the panel of
antibiotics used included different generation of )5-lactams as well as a ̂-lactamase
inhibitor (Table 1).
tetracycline, erythromycin and ampicillin were
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RESULTS
Data from first antibiotic susceptibility testing of the environmental isolates
showed a high level of resistance towards vancomycin and Linezolid which is expected
with gram negative strains. All environmental isolates were extremely susceptible to
Ciprofloxacin with complete inhibition of growth (MICs) at ̂ .06jLtg/ml (Table 3.1). All
isolates were susceptible to tetracycline with MICs ̂ .74/ig/ml (Table 3.1). Ampicillin
susceptibility varied with MICs ranging from 14.22 to 128.0 /tg/ml (Table 3.1).
Antibiotic susceptibility testing was repeated for all environmental isolates from
the first except for strains FD2, D3,132 and F5. This time only antibiotics from the
classes /3-lactams, tetracycline and macrolide were selected (Table 1). The MICs for
tetracycline obtained from this testing were consistent with that from the first one (Table
3.1). Tetracycline was effective in all isolates with MICs ̂ .7 /ig/ml (Table 3.3). MICs
of ampicillin were >42.67/xg/ml (Table 3.3). All isolates showed significantly high
resistance to cephalosporin C with MICs of >128.0jLtg/ml (Table 3.3). 75% of the isolates
tested were resistant to erythromycin with MICs > 50/xg/ml (Table 3.3).
The third antibiotic susceptibility testing included antibiotics of different
generations of /3-lactams along with /3-lactamase inhibitor and a monobactam (Table 1).
The isolates and the control strains were relatively most susceptible to the second and the
third generation cephalosporin - cefoxitin and ceftazidime, respectively (Table 3.4 and
3.5). The MICs of cefoxitin were <1.58jLtg/ml (Table 3.4) while that of ceftazidime were
<14.22/xg/ml (Table 3.4). Susceptibility towards benzylpenicillin, ampicillin and
carbenicillin was varied with isolates and the control strains. MIC of benzylpenicillin
ranged from 0.06-128.0 jug/ml (Table 3.4). MIC of ampicillin ranged from 0.18 to
38
128.0|zg/ml (Table 3.4). MIC of carbenicillin ranged from O.lSjug/ml (Table 3.4). All
environmental isolates except strain FD2 were susceptible to aztreonam. Only strains
124, F7 and F18 along with E. coli ATCC® 25922 and E. coli ATCC® 35218 were tested
against tazobactam, the i^-Iactamase inhibitor. MICs of tazobactam for the control strains
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Figure 10. Minimum Inhibitory Concentration
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Figure 11. Minimum Bactericidal Concentraion
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DISCUSSION
Antibiotic resistance by bacteria can be an intrinsic or an acquired property. In
either case, it enables bacteria to modify the target site of the antibiotic, produce an
enzyme that modifies the antibiotic, alter biochemical pathways to exclude the antibiotic
and develop mechanisms to transport the antibiotic out of the cell. Beside these
mechanisms, bacteria’s chief defense against antibiotic is the cell wall. Gram-negative
bacteria are especially resistant to jS-lactam antibiotics, which target peptidoglycan
synthesis in cell wall of bacteria, because their cell-wall is diminished.
NCCLS specified MIC interpretive standards (gg/ml) for Enterobacteriaceae was
used in this antimicrobial testing to detemiine the level of antibiotic susceptibility of the
isolates (NCCLS M100-S12 2002). In addition, results of this study were also compared
with Houndt and Ochmans’ detennination of high-level resistance to antibiotics and
background levels of antibiotic resistance. According to Houndt, in general, high-level
resistance means resistance to concentrations of >50 gg/ml, whereas background levels
were less than 10 to 20jLig/ml depending on the antibiotic (Houndt and Ochman 2000).
Background level of resistance to a particular antibiotic suggests an inherent nature of
bacteria to resist that antibiotic.
The environmental isolates selected for antibiotic susceptibility testing
classified as being gram-negatives. A broad range of antibiotics were selected for
antibiotic susceptibility testing of 12 environmental isolates (see Methods and Materials)
to detemiine the pattern of antibiotic resistance of these isolates. According to NCCLS
definition and specification, 83.3% of the isolates tested
towards ampicillin. 80.0% of the isolates found to be resistant to ampicillin showed
are
found to be resistantwere
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high level of resistance to ampicillin. The remaining 12.3% ofthe isolates still showed
background level of resistance to ampicillin. 92% of the isolates were found to show high
level of resistance to linezolid which is expected of gram negative bacteria. After
ampicillin, high level of antibiotic resistance was seen in decreasing order towards
vancomycin, erythromycin, streptomycin, rifampicin and chlormaphenicol. The result of
this antibiotic susceptibility testing suggests that perhaps there is a general presence of
multidrug resistance pattern. On the contrary, 75% ofthe isolates were susceptible to
tetracycline. The remaining 25% of the isolates were designated as being intermediate in
terms of resistance to tetracycline. Many earlier studies have shown that bacteria resistant
to tetracycline are capable of tetracycline efflux (Levy 1984) which enables the bacteria
to resist the entry of the drug into the bacterial cell. Therefore, it could be that the
environmental isolates not susceptible to tetracycline are capable of tetracycline efflux.
Although there are reports suggesting alteration of tetracycline target site (ribosome), the
exclusive mechanism for tetracycline resistance has involved decreased penetration ofthe
drug into the cell (Levy 1984).
With this result at hand, a second round of antibiotic susceptibility testing was
performed. This time 8 out of the 12 prior isolates were tested against tetracycline,
ampicillin, erythromycin and cephalosporin C. These antibiotics represent the common
classes of antibiotics. Resistance to ampicillin was observed as anticipated from previous
results. Growth inhibition of 75% environmental isolates due to erythromycin was seen
only in higher concentrations of erythromycin (Table 3.3). This portion ofthe isolates
showed high-level of resistance to erythromycin. All environmental isolates tested were
susceptible to tetracycline (Table 3.3). In addition, growth inhibition of all environmental
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isolates due to cephalosporin C was seen at the highest test concentration (128.0^g/ml) or
greater (Table 3.3). Cephalosporin C is the parent compound ofa number of semi¬
synthetic antibiotics that are used in the treatment of infections due to gram-positive and
gram-negative bacteria. Again, the high level of resistance to cephalosporin C, ampicillin
and erythromycin could suggest the presence of a multidrug resistance pattern in these
environmental isolates.
To evaluate if the environmental isolates showed any difference in resistance
level to different generation of j8-lactams, we performed another antibiotic susceptibility
testing. Accordingly, this test included different generation ofjS-lactams as well as a
monobactam (Aztreonam) and a jS-lactamase inhibitor (Tazobactam).
Resistance to ampicillin, benzylpenicillin and carbenicillin was observed as
expected of previous results. 77.8%, 44.4% and 33.3% of the environmental isolates
tested were found to exhibit high-level resistance to benzylpenicillin, ampicillin and
carbenicillin, respectively. This result suggests the possibility of a multidmg resistance
pattern among the environmental isolates. 100% ofthe isolates were found to be
susceptible to cefoxitin. Cefoxitin possess a significant gram-negative and gram-positive
activity although a significant number of strains including are now
resistant (Fisher, 1984). Cefoxitin falls in the second generation of cephalosporin.
Similarly, 77.77% of the environmental isolates tested were susceptible to ceftazidime,
with the remaining 23.23% still below the resistance level. Ceftazidime is a third
generation cephalosporin. Ceftazidime is a potent broad-spectrum  antibiotics exhibiting
high stability to /8-lactamases, may also be a /S-lactamase inhibitor (Bush and Sykes
1984). The primary basis for the expanded spectrum is improved jS-lactamase stability
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(Bimbaum el al. 1978). Susceptibility to aztreonam was also observed. Aztreonam is a
potent antimicrobial agent as well as )3-lactamase inhibitors (Bush and S^es 1984).
Tazobaclam displayed less inhibitory effect on the environmental isolates. Tazobactamis
a /3-lactamase inhibitor. However in this study it was not used synergistically withajS-
lactam. Therefore, there was no jS-lactam substrate for jS-lactamase, if any produced by
the isolates, to act on. Tazobactam does not have any hydrolyzing capability. Hence,
majority of the isolates showed growth in the presence of tazobactam.
The consistent trend of resistance to ampicillin and earlier generation of jS-lactams
(such as Cephalosporin C) suggests that the environmental isolates tested are resistant
against /3-lactams, at least the earlier generations of jS-lactams. jS-lactam is an important
class of antibiotics because it is widely used for clinical treatment of infections.
Resistance to /3-lactams has been attributed to the production of j3-lactamase enzymes by
bacteria and in recent years to the extended-spectrum-jS-lactamase enzymes. The |8-
lactamase enzyme hydrolyzes the jS-lactam ring and renders the effect of these antibiotics.
There are different generations of j8-lactams available based on their antimicrobial
activity and resistance to /3-lactamase. Bulkier j8-lactam ring is a characteristic of
subsequent generations of /3-lactams. The additional steric hindrance around the ]3-lactam
ring provides a protective shield against specificity of the hydrolytic action of
lactamase. The environmental isolates tested were resistant to simpler j3-lactams but
appeared relatively susceptible to the newer generation of j3-lactams. The level of
resistance suggests acquired resistance. Further testing needs to be done to asses if the
gene encoding /3-lactamase enzyme is intrinsic or acquired.
60
In this study, the environmental pool of resistance was assessed among
rhizosphcrc bacteria because genetic exchange and transfer of antibiotic resistant genes
may be enhanced in the rhizosphere (Halda-AIija, et al. 2000). Establishing an antibiotic
resistance pattern among enteric bacteria in the environment could be potentially used as
warning of possible contamination and as bio-index ofwater and soil/sediment quality
deterioration. This will significantly contribute to the long-term protection of human
health and freshwater wetlands.
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